TGFB1 and infarction: In experimental models, TGF-β signaling blockade markedly alleviates post-infarction fibrosis and enhances cardiac function, consistent with the pharmacological targets of TGF-β1, which appears as an effective target to prevent maladaptive remodeling [52].